SLFN11 gene

Known as: Schlafen Family Member 11 Gene, FLJ34922, SLFN11 
This gene plays a role in anti-viral defense.
National Institutes of Health

Topic mentions per year

Topic mentions per year

2010-2018
0246820102018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
PURPOSE PARP inhibitors (PARPi) are a novel class of small molecule therapeutics for small cell lung cancer (SCLC… (More)
Is this relevant?
2017
2017
Small cell lung cancer is initially highly responsive to cisplatin and etoposide but in almost every case becomes rapidly… (More)
Is this relevant?
2016
2016
Platinum-derived drugs such as cisplatin and carboplatin are among the most commonly used cancer chemotherapy drugs, but very few… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2016
2016
High expression levels of SLFN11 correlate with the sensitivity of human cancer cells to DNA-damaging agents. However, little is… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2016
2016
Poly(ADP-ribose) polymerase inhibitors (PARPIs) kill cancer cells by trapping PARP1 and PARP2. Talazoparib, the most potent PARPI… (More)
  • figure 1
Is this relevant?
2015
2015
PURPOSE SLFN11 was identified as a critical determinant of response to DNA-targeted therapies by analyzing gene expression and… (More)
Is this relevant?
2015
2015
PURPOSE To determine the pharmacokinetics and the antitumor activity in pediatric cancer models of MM-398, a nanoliposomal… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2012
2012
DNA-damaging agents (DDAs) constitute the backbone of treatment for most human tumors. Here we used the National Cancer Institute… (More)
Is this relevant?
Highly Cited
2012
Highly Cited
2012
In mammals, one of the most pronounced consequences of viral infection is the induction of type I interferons, cytokines with… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 4
Is this relevant?